|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.34 EUR | +0.51% |
|
+1.70% | -10.13% |
| 05-18 | Sanofi's rare lung disease drug outperforms standard care in trial | RE |
| 05-18 | Sanofi says rare lung disease drug outperforms standard care in trial | RE |
MarketScreener Strategies
Search
 | Sanofi: Quarterly beat is fine, but longer-term growth prospects remain questionable | April 23, 2026 at 07:35 pm |
 | Sanofi: Treatment for re-rating isn’t easy | April 07, 2026 at 03:16 pm |
 | Sanofi prepares for the future and once again raises its sacrosanct dividend | January 30, 2026 at 03:04 pm |
 | Sanofi: More than operational delivery, markets seek pipeline answers | January 29, 2026 at 07:11 pm |
| Sanofi reduces valuation after R&D setbacks | December 31, 2025 at 09:03 am |
 | Sanofi : In the hot seat | October 30, 2023 at 01:52 pm |
No results for this search
Filters
Headlines
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition